Circumferential aerosol device

US10016582B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10016582-B2
Application numberUS-201414292481-A
CountryUS
Kind codeB2
Filing dateMay 30, 2014
Priority dateFeb 7, 2008
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application discloses devices and methods for delivering a therapeutic compound to the olfactory epithelium of an animal or human. The device having one or more channels for imparting a circumferential and axial velocity to the discharged fluid, and an outlet that discharges an aerosol spray having a circumferential and axial velocity as it enters the nasal cavity of a user. The device is designed to displace the air in the upper nasal cavity in order to specifically deposit a therapeutic agent on the olfactory epithelium while minimizing pressure and discomfort experienced by the user.

First claim

Opening claim text (preview).

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A pressurized olfactory drug delivery device comprising: (a) a container comprising a mixture of a pressurized fluid and a therapeutic compound, the container at a distal end of the pressurized olfactory drug delivery device; (b) a nozzle delivery device defining a longitudinal axis and having: (i) an inner axial member having a cylindrical core, (ii) a plurality of helical channels, the helical channels having a radial dimension, a basal surface, and an apical surface, wherein the basal surface is in contact with an outer surface of the axial member, and (iii) an outer cylindrical member in contact with the apical surface of the helical channels, and (c) a metering device configured for selectively discharging the mixture of a pressurized fluid and a therapeutic compound through the helical channels; wherein each helical channel comprises an inlet for receiving the mixture of a pressurized fluid and a therapeutic compound, and an outlet for discharging the mixture of a pressurized fluid and a therapeutic compound, the outlets being located at a proximal-most end of the pressurized olfactory drug delivery device, each outlet is configured to produce an aerosol spray having an axial velocity and circumferential velocity, such that the axial velocity and the circumferential velocity produced by each outlet converge into a single spray plume having a circumferential velocity. 2. The pressurized olfactory drug delivery device of claim 1 , further comprising a conical extension, the conical extension located at the proximal-most end of the pressurized olfactory drug delivery device and congruent with the inner axial member. 3. The pressurized olfactory drug delivery device of claim 1 , wherein the helical channels spiral around the longitudinal axis. 4. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound comprises at least one of small molecules, peptides, proteins, antibodies, antibody fragments, aptamers, or nucleic acids. 5. The pressurized olfactory drug delivery device of claim 1 , wherein the device delivers liquid or lyophilized therapeutic compounds. 6. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound is delivered as a formulation comprising stabilizers, preservatives, or additives. 7. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound is delivered as a formulation comprising colloids, nanoparticles, liposomes, or micelles.

Assignees

Inventors

Classifications

  • A61M31/00Primary

    Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title

  • Inhaling devices inserted into the nose · CPC title

  • of the injector type · CPC title

  • producing a swirling discharge · CPC title

  • the outlet orifices for jets constituted by a liquid or a mixture containing a liquid being disposed on a circle · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10016582B2 cover?
The present application discloses devices and methods for delivering a therapeutic compound to the olfactory epithelium of an animal or human. The device having one or more channels for imparting a circumferential and axial velocity to the discharged fluid, and an outlet that discharges an aerosol spray having a circumferential and axial velocity as it enters the nasal cavity of a user. The dev…
Who is the assignee on this patent?
Univ Washington Through Its Center For Commercialization
What technology area does this patent fall under?
Primary CPC classification A61M31/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).